Submitted by Anonymous (not verified) on Mon, 02/11/2019 - 15:35
J&J's nasal antidepressant heads for FDA panel FierceBiotechJohnson & Johnson's new antidepressant esketamine comes in front of an FDA advisory committee tomorrow, hoping to end a drought in novel therapies for the ...
Submitted by Anonymous (not verified) on Mon, 02/11/2019 - 13:00
The Antidepressant Myth Medical News BulletinMyth: Antidepressant use by fathers affects the birth outcome of the child. A lot of research has been done to study the effects of women using antidepressants ...